Under new ownership after being acquired by GHO Capital, the company will consider expanding its business through acquisitions and moving into new geographies.
The researchers identified 122 potential immune response drivers that could serve as targets for drug research efforts.
A new study from researchers at Stanford showed that nondiagnostic exomes should be re-evaluated as new data on disease-related variants is reported.
Sentieon's first products re-implement the Broad's GATK and MuTect but offer 10-fold, and in some cases 20- to 50-fold, increases in processing speed.
The company plans to launch the 12-protein panel as a CLIA test for longitudinal monitoring of cardiovascular disease, kidney disease, and diabetes.
In Science this week: new chromatin imaging approach, and more.
University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.
Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.
Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.